labetalol hydrochloride
- Product NDC
- 72611-734
- 11-digit product format
- 726110734
- Labeler code
- 72611
- Product ID
- 72611-734_1b19a392-c1b4-67ed-b6ac-c440d5cb7464
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- labetalol hydrochloride
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Almaject, Inc.
- Application
- ANDA090699
- Marketing category
- ANDA
- Marketing start
- 2020-06-01
- Marketing end
- 0000-00-00
- Substance
- LABETALOL HYDROCHLORIDE
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72611-734-01 | 72611073401 | 1 VIAL, MULTI-DOSE in 1 CARTON (72611-734-01) > 20 mL in 1 VIAL, MULTI-DOSE | 2020-06-01 | 0000-00-00 | No | No | Current |